Nivicof

Nivicof

carbocisteine

Manufacturer:

Medhaus

Distributor:

Medhaus
Full Prescribing Info
Contents
Carbocisteine.
Description
Each mL contains: Carbocisteine 50 mg.
Each 5 mL (1 teaspoonful) contains: Carbocisteine 100 mg.
Each capsule contains: Carbocisteine 500 mg.
Action
Absorption and Fate: Carbocisteine is absorbed from the gastrointestinal tract and excreted in the urine as unchanged drug and metabolites.
Indications/Uses
For the respiratory tract disorders characterized by excessive viscous mucus such as bronchitis, otitis, bronchiectasis, emphysema, rhinitis and rhinopharyngitis.
Dosage/Direction for Use
50 mg/mL Suspension (Oral Drops): Infants: 9-12 months: 1.0 mL; 6-8 months: 0.75 mL; 3-5 months: 0.5 mL; below 2 months: 0.25 mL.
To be taken 3 to 4 times a day or as prescribed by the physician.
100 mg/5 mL Syrup: 2-5 years old: 1 teaspoonful (5 mL); 6-12 years old: 2 teaspoonfuls (10 mL).
Adults: 1-1½ tablespoonfuls (15-22.5 mL).
Every 6 hours or as prescribed by the physician.
Capsule: Adults: One capsule three times a day or as prescribed by the physician.
Contraindications
It should be used with caution in elderly patients with severe respiratory insufficiency or in asthmatic patients.
Adverse Reactions
Nausea, headache, gastric discomfort, diarrhea, gastrointestinal bleeding and skin rash have occasionally occurred with Carbocisteine.
Storage
Store at temperatures not exceeding 30°C.
Shake well before using (Oral Drops).
MIMS Class
Cough & Cold Preparations
ATC Classification
R05CB03 - carbocisteine ; Belongs to the class of mucolytics. Used in the treatment of wet cough.
Presentation/Packing
Cap 500 mg x 100's. Syr 100 mg/5 mL x 60 mL. Oral drops 50 mg/mL x 15 mL.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in